Synthetic Biology Approaches for Dynamic CHO Cell Engineering
Overview
Affiliations
Fed-batch culture of Chinese hamster ovary (CHO) cells remains the most commonly used method for producing biopharmaceuticals. Static CHO cell-line engineering approaches have incrementally improved productivity, growth and product quality through permanent knockout of genes with a negative impact on production, or constitutive overexpression of genes with a positive impact. However, during fed-batch culture, conditions (such as nutrient availability) are continually changing. Therefore, traits that are most beneficial during early-phase culture (such as high growth rate) may be less desirable in late phase. Unlike with static approaches, dynamic cell line engineering strategies can optimise such traits by implementing synthetic sense-and-respond programmes. Here, we review emerging synthetic biology tools that can be used to build dynamic, self-regulating CHO cells, capable of detecting intra-/extracellular cues and generating user-defined responses tailored to the stage-specific needs of the production process.
Optimization of a novel expression system for recombinant protein production in CHO cells.
Zhang J, Du C, Pan Y, Zhang Z, Feng R, Ma M Sci Rep. 2024; 14(1):24913.
PMID: 39438721 PMC: 11496728. DOI: 10.1038/s41598-024-76995-6.
Detection of host cell microprotein impurities in antibody drug products.
Tzani I, Castro-Rivadeneyra M, Kelly P, Strasser L, Zhang L, Clynes M Nat Commun. 2024; 15(1):8605.
PMID: 39366928 PMC: 11452709. DOI: 10.1038/s41467-024-51870-0.
Advancements in CHO metabolomics: techniques, current state and evolving methodologies.
Singh R, Fatima E, Thakur L, Singh S, Ratan C, Kumar N Front Bioeng Biotechnol. 2024; 12:1347138.
PMID: 38600943 PMC: 11004234. DOI: 10.3389/fbioe.2024.1347138.
Ying B, Kawabe Y, Zheng F, Amamoto Y, Kamihira M Cells. 2023; 12(22).
PMID: 37998372 PMC: 10670205. DOI: 10.3390/cells12222638.
Meskova K, Martonova K, Hrasnova P, Sinska K, Skrabanova M, Fialova L Antibodies (Basel). 2023; 12(3).
PMID: 37606435 PMC: 10443350. DOI: 10.3390/antib12030051.